glp 1 agonist price GLP-1 Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 Receptor Agonist Market Size,
Description
Natl Cancer Inst
Patients typically begin with a low dose usually 0.25 mg of semaglutide and increase the dosage every four weeks
A pivotal 2021 clinical study of more than 1,900 adults, known as the STEP 1 trial, laid the groundwork for the use of these drugs as a treatment for weight loss
Rarely, the medications may cause thyroid cancer among high-risk patients
